Synthesis of 2-(2-hydroxyethyl)-1-(2-hydroxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline and pseudosymmetry in its crystal structure

被引:2
作者
Turgunov, Kambarali K. [1 ]
Zhurakulov, Sherzod N. [1 ]
Englert, Ulli [2 ]
Vinogradova, Valentina I. [1 ]
Tashkhodjaev, Bakhodir [1 ]
机构
[1] Acad Sci Uzbek, S Yunusov Inst Chem Plant Subst, Mirzo Ulugbek Str 77, Tashkent 100170, Uzbekistan
[2] Rhein Westfal TH Aachen, Inst Inorgan Chem, Landoltweg 1, D-52056 Aachen, Germany
来源
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY | 2016年 / 72卷
关键词
isoquinoline; medicinally active compounds; O-H center dot center dot center dot N hydrogen bonds; pseudosymmetry; crystal structure; NMR analysis;
D O I
10.1107/S2053229616010792
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Natural and synthetic isoquinoline alkaloids display a wide variety of potent biological activities. The title 1-ary1-2-hydroxyethy1-1,2,3,4-tetrahydroisoquinoline, Ci(9)H(23)NO(4), crystallizes with two molecules in the asymmetric unit related by pseudo-translation but differing only slightly in conformation. The pseudosymmetry is also reflected in the diffraction pattern. The subset of reflections corresponding to the smaller cell and average structure are on average twice as intense as those subtending the larger cell. Tentative refinement in the subcell leads to a disordered structural model with satisfactory agreement factors and, after appropriate use of restraints, acceptable molecular geometry but significantly larger and more anisotropic displacement parameters. In the correct unit cell, the independent molecules differ with respect to the orientation of the hydroxyethyl group. Intramolecular hydrogen bonding occurs between the hydroxyphenyl group and the N atom.
引用
收藏
页码:607 / +
页数:14
相关论文
共 12 条
  • [1] [Anonymous], 2002, SMART
  • [2] [Anonymous], 2009, SAINT
  • [3] [Anonymous], XP
  • [4] Bruker AXS Inc, 2008, SADABS
  • [5] Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist
    Gitto, R
    Barreca, ML
    De Luca, L
    De Sarro, G
    Ferreri, G
    Quartarone, S
    Russo, E
    Constanti, A
    Chimirri, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (01) : 197 - 200
  • [6] Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI 10.1107/S0021 88980600731X
  • [7] Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists
    Naito, R
    Yonetoku, Y
    Okamoto, Y
    Toyoshima, A
    Ikeda, K
    Takeuchi, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6597 - 6606
  • [8] X-ray structure investigations of potential beta-blockers .2. 6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline
    Olszak, TA
    Stepien, A
    Grabowski, MJ
    Brzezinska, E
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1996, 52 : 1038 - 1040
  • [9] A short history of SHELX
    Sheldrick, George M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : 112 - 122
  • [10] Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053273314026370, 10.1107/S2053229614024218, 10.1107/S0108767307043930]